The global market for lab-based immunoassays, inclusive of both infectious disease and non-infectious disease analytes and instruments, reached $27 billion in 2023 and is forecast to experience modest growth in the foreseeable future. The findings are based on data published in In Vitro Diagnostics Business Outlook, 2024, a bi-monthly newsletter focused on global IVD products […]
Diagnostic testing is now a cornerstone of healthcare, assisting physicians in diagnosing conditions and prescribing treatments. Demand for in vitro diagnostic (IVD) testing has remained strong across various segments, with sales generally increasing throughout 2023. Global IVD market sales surpassed $100 billion in 2023, according to In Vitro Diagnostic (IVD) Trends and Market Update: March […]
In recent years, there has been a noticeable increase in diagnostic testing within animal healthcare, attributed to a surge in pet ownership and the emergence of various zoonotic diseases. Diagnostic testing plays a crucial role in animal healthcare, offering veterinarians a diverse range of tests for disease identification and monitoring. The efficacy of diagnostic testing […]
In 2023, global liquid biopsy market sales exceeded $1 billion. Projections indicate a substantial growth trajectory, with an anticipated average annual double-digit growth rate over the next several years. By 2028, the market’s growth will reflect significant momentum and rapid expansion during the forecast period. This is according to The Worldwide Market for Liquid Biopsy, […]
January is Cervical Health Awareness Month, a reminder that more than 95% of cervical cancer cases are attributed to the human papillomavirus (HPV), according to the World Health Organization (WHO). HPV testing is a key segment of the double-digit, multi-billion-dollar global molecular diagnostic testing market, according to the new report The World Market for Molecular […]
One of the most explored applications of molecular diagnostics is oncology, a segment with sales exceeding $6 billion in 2023, according to new data published in Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028, now on sale by leading medical and diagnostic market research firm Kalorama Information. In the report, the oncology segment is […]
The global market for LIS is forecast to increase at a high single-digit compound annual growth rate (CAGR) between 2022 and 2027, reveals leading medical market research publisher Kalorama Information in the new report World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027. Advances in healthcare will function as […]
The in vitro diagnostic (IVD) industry is on track again after the disruptions of the pandemic. The overall volume of IVD procedures will rise steadily throughout most of the world, boosted by aging population trends, proliferating epidemiological patterns, increasing availability of healthcare funding, and widespread adoption of patient care strategies that emphasize early disease detection […]
In vitro diagnostics (IVDs) remain dynamic. The IVD market is a high R&D spend industry with constant innovations and routine interest from venture capital firms in diagnostic products. Nevertheless, the past few years have been very disruptive for IVDs. However, the resilient IVD industry has weathered the pandemic and is forging ahead with new technologies […]
The need for veterinary testing has grown in recent years, as the majority of U.S. households claim to have at least one pet in the family. This has created ample opportunity for the companion animal segment of the veterinary diagnostic market, which globally had sales of $2.7 billion in 2022. The findings are according to […]
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
